Glaxosmithkline Biologicals SA

Glaxosmithkline Biologicals SA is a company in Rixensart, Belgium that has taken part in 27 EU-funded projects since 2010, receiving €15.1M in EU funding and leading 4 as coordinator.

EU funding received€15.1M
EU projects27
As coordinator4
Running now4
First EU project2010
Latest project2024
CountryBelgium
EU registration (PIC)994851886
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Glaxosmithkline Biologicals SA's own share of each project, not the project's full budget.

  • Horizon 2020€14.1M · 13 projects
  • FP7 (2007 to 2013)€1.0M · 12 projects
  • Horizon Europe€0 · 1 project
  • Erasmus+ (ERASMUS+)€0 · 1 project

Projects

27 EU-funded projects, newest first. Glaxosmithkline Biologicals SA led 4 of them as coordinator. Each links to the official record.

  • Project-COMFORTAssociated partner

    Patient-Centric blOod saMpling FOr impRoved healThcare (Project-COMFORT)

    Horizon Europe · 2024–2028 · Project on CORDIS ↗

  • LIVE_InnovAssociated partner

    Leading International Vaccinology Education for Innovation

    Erasmus+ (ERASMUS+) · 2024–2030 · Project on the EU portal ↗

  • PROMISEPartner

    Preparing for RSV Immunisation and Surveillance in Europe

    Horizon 2020 · 2021–2024 · Project on CORDIS ↗

  • PrIMAVeRaPartner

    Predicting the Impact of Monoclonal Antibodies & Vaccines on Antimicrobial Resistance

    Horizon 2020 · 2021–2026 · Project on CORDIS ↗

  • Inno4VacPartner

    Innovations to accelerate vaccine development and manufacture

    Horizon 2020 · 2021–2028 · Project on CORDIS ↗

  • Vacc-iNTSAssociated partner

    Advancing a GMMA-based vaccine against invasive non-typhoidal salmonellosis through Phase 1 trial in Europe and sub-Saharan Africa

    Horizon 2020 · 2019–2026 · Project on CORDIS ↗

  • VITALPartner

    Vaccines and Infectious Diseases in the Ageing PopuLation

    Horizon 2020 · 2019–2024 · Project on CORDIS ↗

  • COMBACTE-CDIPartner

    Combatting Bacterial Resistance in Europe - Clostridium Difficile Infections

    Horizon 2020 · 2017–2021 · Project on CORDIS ↗

  • DRIVEPartner

    Development of Robust and Innovative Vaccine Effectiveness

    Horizon 2020 · 2017–2022 · Project on CORDIS ↗

  • RESCEUPartner

    REspiratory Syncytial virus Consortium in EUrope - Sofia ref.: 116019

    Horizon 2020 · 2017–2022 · Project on CORDIS ↗

  • PERISCOPEPartner

    PERtussIS COrrelates of Protection Europe - Sofia ref.: 115910

    Horizon 2020 · 2016–2022 · Project on CORDIS ↗

  • VAC2VACPartner

    Vaccine lot to Vaccine lot comparison by consistency testing.

    Horizon 2020 · 2016–2022 · Project on CORDIS ↗

  • FLUCOPPartner

    Standardization and Development of Assays for Assessment of Influenza Vaccines Correlates of Protection

    FP7 (2007 to 2013) · 2015–2020 · Project on CORDIS ↗

  • DiViNeAssociated partner

    Sustainable downstream processing of vaccines through incorporation of nanobiotechnologies : novel affinity ligands and biomimetic membranes

    Horizon 2020 · 2015–2020 · Project on CORDIS ↗

  • TBVAC2020Partner

    TBVAC2020; Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development

    Horizon 2020 · 2015–2019 · Project on CORDIS ↗

  • EbolaVacCoordinator

    Development of a Chimpanzee Adenovirus Type 3 Ebolavirus Zaire Vaccine

    Horizon 2020 · 2014–2018 · Project on CORDIS ↗

    €14.1Mtheir share
  • EXALTPartner

    Proposal to assess an innovative Immunotherapy, based on a thioredox peptide antigen, in a Phase I Trial for Type-1 Diabetes

    FP7 (2007 to 2013) · 2014–2019 · Project on CORDIS ↗

    €285ktheir share
  • DAVIADPartner

    The development of a novel therapeutic vaccine for the selective treatment of the autoimmune disorder, Graves’ disease

    FP7 (2007 to 2013) · 2013–2018 · Project on CORDIS ↗

    €15ktheir share
  • ADVANCEPartner

    Accelerated Development of Vaccine benefit-risk Collaboration in Europe

    FP7 (2007 to 2013) · 2013–2019 · Project on CORDIS ↗

  • ADJSYNCoordinator

    Understanding how immunostimulant combinations in adjuvants synergise to enhance vaccine responses

    FP7 (2007 to 2013) · 2013–2015 · Project on CORDIS ↗

    €170ktheir share
  • T-BACCoordinator

    Exploring the roles and plasticity of T-cell responses in anti-BACterial immunity

    FP7 (2007 to 2013) · 2013–2015 · Project on CORDIS ↗

    €170ktheir share
  • PEACHIPartner

    Prevention of hepatitis C virus (HCV) and HIV-1 co-infections through induction of potent T cell responses using prime-boost viral vector vaccine regimens

    FP7 (2007 to 2013) · 2013–2017 · Project on CORDIS ↗

  • MultiMalVaxPartner

    A Multi-Stage Malaria Vaccine

    FP7 (2007 to 2013) · 2012–2017 · Project on CORDIS ↗

    €25ktheir share
  • BIOVACSAFEPartner

    Biomarkers For Enhanced Vaccine Safety

    FP7 (2007 to 2013) · 2012–2018 · Project on CORDIS ↗

  • ADITECPartner

    Advanced Immunization Technologies

    FP7 (2007 to 2013) · 2011–2017 · Project on CORDIS ↗

  • SIMULATACoordinator

    System for Immunological Modelling as an Ultimate tool to Link Adjuvant function To Adaptive immune responses

    FP7 (2007 to 2013) · 2010–2012 · Project on CORDIS ↗

    €221ktheir share
  • NEWTBVACPartner

    Discovery and preclinical development of new generation tuberculosis vaccines

    FP7 (2007 to 2013) · 2010–2014 · Project on CORDIS ↗

    €150ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • HIV
  • alkali metals
  • antibiotic resistance
  • antibiotics
  • asthma
  • autoimmune diseases
  • bacteriology
  • big data
  • biomolecules
  • carbohydrates
  • data mining
  • databases
  • diabetes
  • differential equations

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime